Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients.
BACKGROUND
It has been proposed that antidepressants can induce a chronic, dysphoric, irritable state in bipolar patients (called ACID for antidepressant-associated chronic irritable dysphoria). This phenomenon has only been described in case series format, and has not been prospectively validated.


METHODS
Prospective data from the first 1500 patients (62.7% with bipolar I, 30.1% with bipolar II, and 7.2% with NOS) treated in the STEP-BD database were examined and those who were euthymic for at least one month at study entry, subsequently developed a depressive episode, and were then followed for one year were identified. Outcome of those who received an antidepressant for this depressive episode (n=27) was compared to those who did not (n=56), with particular attention given to the presence of the proposed symptom triad of ACID, namely dysphoria, irritability, and middle insomnia.


RESULTS
Patients treated with antidepressants were ten times more likely to develop ACID than those who were not (Hazard ratio=9.95, CI=1.103-89.717, P=0.04). However, the hazard ratio dropped to 1.05 (P=0.99) when corrected for significant covariates, notably past antidepressant-related manic switch and sex.


CONCLUSIONS
This study does not support the existence of ACID as an independent phenomenon. Rather, ACID appears to be part of a broader spectrum of antidepressant treatment-emergent affective switches.
Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, 501 East Broadway, MedCenter One, Suite 340, Louisville, Kentucky 40202, United States. rselma01@luisville.edu
Rif S
RS
El-Mallakh
S Nassir
SN
Ghaemi
Kemal
K
Sagduyu
Michael E
ME
Thase
Stephen R
SR
Wisniewski
Andrew A
AA
Nierenberg
Hong Wei
HW
Zhang
Tamara A
TA
Pardo
Gary
G
Sachs
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D017668:Age of Onset; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D007508:Irritable Mood / Q000187:drug effects; D008137:Longitudinal Studies; D008297:Male; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales; D012720:Severity of Illness Index; D012737:Sex Factors; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D016019:Survival Analysis; D016896:Treatment Outcome
D000928:Antidepressive Agents